David Schaaf
Technik-/Wissenschafts-/F&E-Leiter bei PDS BIOTECHNOLOGY CORPORATION
Aktive Positionen von David Schaaf
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2022 | - |
Karriereverlauf von David Schaaf
Ehemalige bekannte Positionen von David Schaaf
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ZOGENIX, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von David Schaaf
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| Stanford University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
- Börse
- Insiders
- David Schaaf
- Erfahrung
